Why is Amerise BioScie falling/rising?

As of 08-Sep, Amerise Biosciences Ltd is currently priced at 0.70, with no change in price (0.00%). The stock has underperformed its sector today by 0.32% and is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, investor participation has decreased significantly, with a delivery volume of 15.73k on September 5, which is down by 72.13% compared to the 5-day average. Over the past year, the stock has seen a decline of 15.66%, while year-to-date, it has fallen by 42.15%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Amerise Biosciences Ltd's short-term performance over the past week shows a decline of 6.67%, while the benchmark Sensex has increased by 0.53%. This indicates that the stock is not only underperforming relative to the market but also struggling significantly compared to the benchmark's performance over various time frames, including a 1-month return of 1.45% for the stock versus 1.16% for the Sensex. Overall, the combination of poor trading performance, reduced investor interest, and a lack of positive factors contributes to the stock's downward trajectory.